Bleomycin: Frequently Asked Questions Answered
What is Bleomycin?
Bleomycin belongs to the class of organic compounds known as hybrid glycopeptide. It is an antibiotics agent which exhibits antineoplastic activity and is used primarily in chemotherapy as an anticancer agent. Initially used as a single agent, it has now been used in combination in chemotherapy. Bleomycin inhibits the uncontrolled cell division in cancer-causing cells by inhibiting DNA synthesis. Bleomycin is therapeutically used to treat malignant neoplasms such as sarcomas, lymphomas, melanomas, and germinal cell cancers. Bleomycin should be used cautiously because of its associated toxicity.
What are the uses of Bleomycin?
Bleomycin is a glycopeptide class antibiotic that shows antitumor activity; hence it is classified as an ‘Anticancer antibiotic.’ Bleomycin is approved for use in adults and can be used alone or with other drugs as palliative treatment and management of malignant neoplasms.
FDA approved therapeutic uses –
- Squamous cell carcinoma
- Gestational thromboplastin disease.
- Germinal cell tumors.
- Hodgkin and Non-Hodgkin’s Lymphoma
Non -FDA approved therapeutic uses –
- Malignant pleural effusions
- Osteosarcoma
- Melanoma
- AIDS-associated Kaposi sarcoma
- Advanced stages of Mycosis Fungoides.